7.66 USD
▲+0.09+3.37%
盘后 7.45 +0.54%
2026-08-03
市值
$1.26B
市盈率
—
EPS
-0.54
股息率
—
52 周区间
6.20 – 11.97
成交量
3.25M
Beta
2.43
目标价
14.11
52W 低 6.2052W 高 11.97
价格走势
公司简介
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in ...